RoActemra
- INN
- tocilizumab
- Forms
- Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion
- Strengths
- 162 mg (syringe, pen) ;20 mg/ml (concentrate)
- Area
- Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection
- Alternatives
- Yes
What is this? RoActemra is a medicine with the active substance tocilizumab. It is used as an injection or infusion for certain types of arthritis, giant cell arteritis, cytokine release syndrome, and COVID-19.
What's happening? There was a supply issue with RoActemra in the EU. The problem has now been fixed.
Does this affect me? If you were using RoActemra, the shortage is over. You can continue your treatment as normal.
What should I do? Check with your pharmacist or doctor if you have any questions about your medicine.
🤖 Este resumen en lenguaje sencillo se genera automáticamente a partir del aviso oficial de la agencia mediante IA. Es solo para fines informativos — no es un consejo médico. Para tomar decisiones sobre su salud, consulte siempre a un farmacéutico o médico y lea la fuente oficial vinculada a continuación.
🔬 Detalles médicos/técnicos Para profesionales
INN: tocilizumab · Forms: Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion · Strengths: 162 mg (syringe, pen) ;20 mg/ml (concentrate) · Area: Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection · Alternatives: Yes
Toda la información de esta página proviene del aviso oficial de la agencia. Nosotros la traducimos y resumimos; no añadimos ni editamos datos.